BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 15224123)

  • 1. The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor.
    Mittendorf R; Roizen NJ; Pryde PG
    J Perinatol; 2004 Jul; 24(7):465-6. PubMed ID: 15224123
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnesium sulfate for preterm neuroprotection.
    Mittendorf R; Lee KS; Roizen NJ; Pryde PG
    JAMA; 2004 Feb; 291(8):940-1; author reply 941. PubMed ID: 14982906
    [No Abstract]   [Full Text] [Related]  

  • 3. Antenatal magnesium sulfate for neuroprotection before preterm birth?
    Stanley FJ; Crowther C
    N Engl J Med; 2008 Aug; 359(9):962-4. PubMed ID: 18753653
    [No Abstract]   [Full Text] [Related]  

  • 4. Magnesium sulfate for preterm neuroprotection.
    Ananth CV; Vintzileos AM
    JAMA; 2004 Feb; 291(8):940; author reply 941. PubMed ID: 14982907
    [No Abstract]   [Full Text] [Related]  

  • 5. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants.
    Costantine MM; Drever N
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):351-66, xi. PubMed ID: 21575805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium sulfate for neuroprotection in patients at risk for early preterm delivery: not yet.
    Sibai BM
    Am J Obstet Gynecol; 2011 Oct; 205(4):296-7. PubMed ID: 22083053
    [No Abstract]   [Full Text] [Related]  

  • 7. Magnesium sulfate for the prevention of cerebral palsy.
    Rouse DJ
    Am J Obstet Gynecol; 2009 Jun; 200(6):610-2. PubMed ID: 19482114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
    Crowther CA; Hiller JE; Doyle LW; Haslam RR;
    JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In defense of magnesium sulfate.
    Elliott JP; Lewis DF; Morrison JC; Garite TJ
    Obstet Gynecol; 2009 Jun; 113(6):1341-1348. PubMed ID: 19461432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium sulfate for the prevention of cerebral palsy.
    Mittendorf R; Pryde PG
    N Engl J Med; 2009 Jan; 360(2):189-90; author reply 190. PubMed ID: 19129535
    [No Abstract]   [Full Text] [Related]  

  • 11. Magnesium sulphate for fetal neuroprotection.
    Costa Fda S; Lopes L; Brennecke S
    Rev Bras Ginecol Obstet; 2011 Jun; 33(6):265-70. PubMed ID: 21877014
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
    Marret S; Marpeau L; Follet-Bouhamed C; Cambonie G; Astruc D; Delaporte B; Bruel H; Guillois B; Pinquier D; Zupan-Simunek V; BĂ©nichou J;
    Gynecol Obstet Fertil; 2008 Mar; 36(3):278-88. PubMed ID: 18337147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection.
    Obstet Gynecol; 2010 Mar; 115(3):669-671. PubMed ID: 20177305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium sulfate for fetal neuroprotection.
    Rouse DJ
    Am J Obstet Gynecol; 2011 Oct; 205(4):296-7. PubMed ID: 22083052
    [No Abstract]   [Full Text] [Related]  

  • 15. What gestation cut-off should be used for magnesium sulfate treatment of women threatening to deliver preterm?
    Knight DB; Gardener GJ
    Am J Obstet Gynecol; 2010 Mar; 202(3):e9; author reply e9-10. PubMed ID: 19889392
    [No Abstract]   [Full Text] [Related]  

  • 16. Hope for perinatal prevention of cerebral palsy.
    Tyson JE; Gilstrap LC
    JAMA; 2003 Nov; 290(20):2730-2. PubMed ID: 14645316
    [No Abstract]   [Full Text] [Related]  

  • 17. Magnesium and the obstetric anaesthetist.
    Dean C; Douglas J
    Int J Obstet Anesth; 2013 Jan; 22(1):52-63. PubMed ID: 23182610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence exists for prophylactic magnesium sulphate as a neuroprotector in premature births].
    Wolf HT; Hegaard HK; Huusom L; Greisen G; Hedegaard M
    Ugeskr Laeger; 2011 Mar; 173(13):962-5. PubMed ID: 21453636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes.
    Horton AL; Lai Y; Rouse DJ; Spong CY; Leveno KJ; Varner MW; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Thorp JM; Ramin SM; Malone FD; O'Sullivan MJ; Hankins GD; Caritis SN;
    Am J Perinatol; 2015 Mar; 32(4):387-92. PubMed ID: 25241107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium sulfate for cerebral palsy prevention.
    Rouse DJ; Gibbins KJ
    Semin Perinatol; 2013 Dec; 37(6):414-6. PubMed ID: 24290398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.